Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
企業コードPRENW
会社名Prenetics Global Ltd
上場日Jul 06, 2021
最高経営責任者「CEO」Mr. Joel Neoh
従業員数- -
証券種類Company Warrant
決算期末- -
本社所在地Unit 703-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay
都市
証券取引所NASDAQ Capital Market Consolidated
国Hong Kong
郵便番号- -
電話番号85222109588
ウェブサイトhttps://ir.prenetics.com/
企業コードPRENW
上場日Jul 06, 2021
最高経営責任者「CEO」Mr. Joel Neoh
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし